Risk that delays in verifying the clinical efficacy of medical devices, obtaining certifications and approvals in various countries, and responding to new regulations, sales regulations, medical cost-reduction policies and other measures may affect time to market, investment returns and competitiveness. This also includes the risk of failing to respond to changes in healthcare systems and the operating environment for hospitals.